A Phase 4 interventional study of Venofer 200 MG Per 10 ML Injection and Ferinject in Anemia, Iron Deficiency and Pregnancy Anemia, sponsored by Western Galilee Hospital-Nahariya. Recruiting at 1 site in Israel. Open to female participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-09-11.
Sponsored by Western Galilee Hospital-Nahariya · Phase 4, Interventional, and Treatment
The purpose of this study is to compare maternal outcomes such as increased hemoglobin need for blood transfusion and hemoglobin level before and post partum in women with hemoglobin \<9 gr/dl , treated with venofer and women treated with ferinject.
600 studies on the registry are indexed under Anemia, Iron-Deficiency; 95 are open to participants now.
This study's planned enrollment of 200 is above the median of 100 across 459 interventional studies indexed under Anemia, Iron-Deficiency.
Browse Anemia, Iron-Deficiency studies →Western Galilee Hospital-Nahariya is the lead sponsor of 89 studies on the registry; 15 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
pregnancy>24 weeks of gestation anemia with \<9 anemia with Hb\<9.5 if symptomatic anemia or previous postpartum hemorrhage
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The protein in red blood cells that carries oxygen. A low level is anaemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).
Hemoglobin (Hb)
The protein in red blood cells that carries oxygen. A low level is anaemia, which can cause tiredness and breathlessness. Measured in g/dL or g/L (9 g/dL is 90 g/L).
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Women with iron def. anemia aith hemoglobin level \<9 gr/dl who will be traeted with venofer
Drug: Venofer 200 MG Per 10 ML Injection
Women with iron def. anemia aith hemoglobin level \<9 gr/dl who will be traeted with ferinject
Drug: Ferinject
treat anemia with venofer up to 5 doses
ferinject 500 mg, once a week for 2 weeks
ratio of women with Hb level >11 at delivery
Hb level
Time frame: at delivery
postpartum Hb level
gr/dl
Time frame: during 48 hours after delivery
Started Nov 2023 (actual). Primary completion is estimated for Sep 2027, 46 months after the start.
Of 43 non-industry phase 4 interventional studies under Anemia, Iron-Deficiency, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 35. This study's planned 46 months is above that.
Counting every sponsor, half of 51 studies reached it within 22 months; a quarter within 15 and three quarters within 35.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Iron sucrose · Ferric carboxymaltose
Western Galilee Hospital-Nahariya